Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
BLX 0.57ELF.TO 0.09RY.TO 3.05PEY.TO 0.26CP.TO -0.12BRK.B -0.57MSFT -5.93META 6.73
Angiotech Pharmaceuticals (ANP.TO)
The ultimate 360° Tracker Your financial life in one place, automatically

Angiotech Pharmaceuticals (ANP.TO)

0.00
-0.00 (0.00%)
2 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
BUY

Angiotech Pharmaceuticals(ANP.TO)

Mar 15, 2002
Very good company and at a good price now.
Photo of Ted MacklinTed MacklinUnlock Rating
$73.30

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Angiotech Pharmaceuticals(ANP.TO)

Mar 14, 2002
Got products moving into markets. New contracts. Prefers Biovale.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$73.85

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Angiotech Pharmaceuticals(ANP.TO)

Mar 06, 2002
Stock has been hit too hard and will recover. Will be volatile.
Photo of Mike WeirMike WeirUnlock Rating
$66.75

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Angiotech Pharmaceuticals(ANP.TO)

Mar 05, 2002
Good prospects on their stent products. Have cash. Use a conservative model so risk is limited.
Photo of John ZechnerJohn ZechnerUnlock Rating
$67.13

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY ON WEAKNESS

Angiotech Pharmaceuticals(ANP.TO)

Mar 04, 2002
Prefers buying in the low $60's. Volatile.
Photo of Ted MacklinTed MacklinUnlock Rating
$65.90

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Angiotech Pharmaceuticals(ANP.TO)

Feb 19, 2002
Good products.
Photo of Nereo PiticcoNereo PiticcoUnlock Rating
$85.40

Stock price when the opinion was issued

biotechnologypharmaceutical
STRONG BUY

Angiotech Pharmaceuticals(ANP.TO)

Jan 24, 2002
Well run. Involved with three large partnerships. Should do very well.
Photo of Brendan KyneBrendan KyneUnlock Rating
$87.08

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Angiotech Pharmaceuticals(ANP.TO)

Jan 10, 2002
Have to start delivering revenues and earnings. Risky.
Photo of Richard StoneRichard StoneUnlock Rating
$86.26

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

Angiotech Pharmaceuticals(ANP.TO)

Dec 05, 2001
(Was a top pick on Aug 24 down 4%) Still likes as a long term hold.
Photo of Martin Hubbes, CFAMartin Hubbes, CFAUnlock Rating
$83.50

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

Angiotech Pharmaceuticals(ANP.TO)

Dec 04, 2001
(Was a top pick on Was a top pick on Aug 23 down 3%) Still likes. Should have some growth. Has good partners.
Photo of Brendan KyneBrendan KyneUnlock Rating
$83.83

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Angiotech Pharmaceuticals(ANP.TO)

Oct 22, 2001
Likes.
Photo of Ted MacklinTed MacklinUnlock Rating
$69.20

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Angiotech Pharmaceuticals(ANP.TO)

Oct 18, 2001
Lots of cash. Good product. Lots of upside.
Photo of John ZechnerJohn ZechnerUnlock Rating
$67.23

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Angiotech Pharmaceuticals(ANP.TO)

Sep 25, 2001
Selected yesterday and it has now just shot up, so wouldn't get into it right away.
Photo of John EmbryJohn EmbryUnlock Rating
$68.80

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Angiotech Pharmaceuticals(ANP.TO)

Sep 07, 2001
Can drop further.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$58.49

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Angiotech Pharmaceuticals(ANP.TO)

Sep 04, 2001
Johnson & Johnson made an announcement on their stent which hit this stock, but they have a smaller stent and expect to make a positive announcement in a week.
Photo of Brendan KyneBrendan KyneUnlock Rating
$71.00

Stock price when the opinion was issued

biotechnologypharmaceutical
Showing 121 to 135 of 140 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

AVGO -17.23$376.71
CCO.TO 1.26$151.04
TOU.TO -0.47$60.79
BTE.TO -0.22$5.91
ADM -1.25$78.02

Today's Top Picks

BLX 0.57$59.24
ELF.TO 0.09$16.98
RY.TO 3.05$281.51
PEY.TO 0.26$24.91
CP.TO -0.12$124.8

Popular Articles

Latest Sell Signals

OTEX.TO 0.14$30.96
BSX 0.16$46.92
GIL.TO -16.24$70.39
SHOP.TO 1.22$158.49
WCN.TO 3.21$219.59

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Keith Richards

Keith Richards

ValueTrend Wealth Management

Joe Terranova

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Rob Sechan, Managing Partner, New Edge Capital

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica